Galderma is the pure-play dermatology category leader, committed to advancing dermatology for every skin story. Leveraging our unique 40-year heritage of leading science-based innovation, we deliver a synergistic portfolio of flagship brands and services that span the full spectrum of dermatology.

Galderma is the leading company solely dedicated to the body’s largest organ: the skin. We are strategically positioned in resilient, highly attractive and consumer-focused sub-segments of Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.

And our unique Integrated Dermatology Strategy capitalizes on our distinctive strengths and competitive advantage. Through trust-based partnerships with healthcare professionals, we meet consumer and patient needs with superior, lasting outcomes. Together, we are shaping the future of dermatology.

Galderma’s rapid growth is supported by superior manufacturing technologies and high-performance operations. We produce over 330 million units annually to serve more than 90 countries at our four manufacturing plants. Over 1600 team members covering manufacturing, commercial quality and supply chain functions operate from our strategically placed sites in Canada, Sweden, France and Brazil.